Through examining thousands of mosquitoes collected Australia-wide, we have discovered a unique insect-specific virus that we have named Binjari virus. By engineering BinJV to mimic the appearance of pathogenic flaviviruses such as Japanese encephalitis, dengue or Zika viruses, we developed a new chimeric technology that accelerates scientific discovery and provides a platform to make the next generation of flavivirus diagnostics, therapies and vaccines.
While these BinJV-based chimeric mimics cannot infect humans and animals, they can be produced in cultured mosquito cells using industry-suitable protocols. The power of the technology has been realised through successful pre-clinical studies in mice showing that the BinJV chimeras as vaccines provide protection using a small single dose against dengue, Zika, West Nile and yellow fever viruses.
Featured PhD & Postdoctoral research
Using mosquito cells to make vaccines against Japanese encephalitis virus
Not just another mosquito virus – a new recombinant platform based on the Yada Yada virus
Journal articles
Media highlights
Vaccine to protect crocodiles and multi-million dollar industry
Vaccine to protect pigs from Japanese encephalitis virus
New insect virus provides a safer platform for flavivirus vaccines and tests
Virus mimic used to create safe vaccines for mosquito-borne diseases
Team Chimera - Eureka Prize 2021 Finalist